文献速递胰腺与胆道疾病消化内镜

急性结石性胆囊炎患者术前胆总管结石预测因素

Preoperative predictors of choledocholithiasis in patients presenting with acute calculous cholecystitis.
PubMed 文献 · Gastrointest Endosc · 2018-11-19

该回顾性研究纳入3.5年间一家三级医院的366例急性结石性胆囊炎患者,其中65例(17.8%)合并胆总管结石。多变量模型显示丙氨酸转氨酶>3倍正常上限、碱性磷酸酶异常和胆总管直径>6 mm可预测胆总管结石,验证队列曲线下面积为0.91;无或仅1个危险因素时98.6%无胆总管结石,3个危险因素均存在时77.8%有胆总管结石。

要点

  • 急性结石性胆囊炎患者中胆总管结石患病率为17.8%(65/366)。
  • 丙氨酸转氨酶>3倍正常上限、碱性磷酸酶异常、胆总管直径>6 mm为预测因素。
  • 验证队列模型曲线下面积0.91;0或1个危险因素时98.6%无胆总管结石,3个危险因素时77.8%有胆总管结石。

核心结论

  • 急性结石性胆囊炎患者中胆总管结石患病率较高,使用丙氨酸转氨酶、碱性磷酸酶和胆总管直径的截断值可有效分诊低概率和高概率胆总管结石患者分别至手术或经内镜逆行胰胆管造影。

研究设计与样本

  • 回顾性研究,纳入3.5年间就诊于一家大型三级医院的急性结石性胆囊炎患者366例,胆总管结石定义为超声、CT、磁共振成像/磁共振胰胆管成像、超声内镜、经内镜逆行胰胆管造影或术中胆管造影中任一检查见胆总管结石、泥沙样或碎屑。
  • 多变量预测模型在70%患者中开发,在剩余30%患者中验证。

主要发现

  • 共识别366例患者,65例(17.8%)合并胆总管结石。
  • 单变量分析显示转氨酶>3倍正常上限、碱性磷酸酶高于正常、脂肪酶>3倍正常上限、总胆红素≥1.8 mg/dL和胆总管直径>6 mm的比值比有统计学意义。
  • 验证队列中,包含丙氨酸转氨酶>3倍正常上限、碱性磷酸酶异常和胆总管直径>6 mm的最优模型受试者工作特征曲线下面积为0.91。
  • 存在0或1个危险因素时,98.6%的患者无胆总管结石;3个危险因素均存在时,77.8%的患者有胆总管结石。

关键数值与推荐

  • 转氨酶>3倍正常上限、碱性磷酸酶高于正常、脂肪酶>3倍正常上限、总胆红素≥1.8 mg/dL、胆总管直径>6 mm在单变量分析中比值比有统计学意义。
  • 验证队列模型包含丙氨酸转氨酶>3倍正常上限、碱性磷酸酶异常和胆总管直径>6 mm,曲线下面积0.91。
  • 0或1个危险因素时98.6%无胆总管结石,3个危险因素时77.8%有胆总管结石。

临床怎么用

  • 作者认为,应用丙氨酸转氨酶、碱性磷酸酶和胆总管直径的截断值可有效将低概率和高概率胆总管结石的急性结石性胆囊炎患者分别分诊至手术或经内镜逆行胰胆管造影。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Markedly increased liver chemistries in patients presenting with acute calculous cholecystitis (AC) often prompt an evaluation for concomitant choledocholithiasis (CDL). However, current guidelines directing the workup for CDL fail to address this unique population. The aims of this study are to define the range of presenting laboratory values and imaging findings in AC, develop a model to predict the presence of concurrent CDL, and develop a management algorithm that can be easily applied on presentation. METHODS: We conducted a retrospective review of patients presenting with AC to a large tertiary hospital over a 3.5-year period. CDL was defined as common bile duct (CBD) stone(s), sludge, or debris seen on any of the following studies: US, CT, magnetic resonance imaging/MRCP, EUS, ERCP, or intraoperative cholangiogram. A multivariable model to predict CDL was developed on 70% of the patients and validated on the remaining 30%. RESULTS: A total of 366 patients were identified and 65 (17.8%) had concurrent CDL. Univariable analysis was used to predict CDL and demonstrated statistically significant odds ratios for transaminases >3 times the upper limit of normal, alkaline phosphatase (AlkPhos) above normal, lipase >3 times the upper limit of normal, total bilirubin ≥1.8 mg/dL, and CBD diameter >6 mm. In the validation cohort, an optimal model containing alanine transaminase (ALT) >3 times the upper limit of normal, abnormal AlkPhos, and CBD diameter >6 mm was found to have an area under the receiver operating curve of 0.91. When 0 or 1 risk factors were present, 98.6% of patients did not have CDL. When all 3 risk factors were present, 77.8% were found to have CDL. CONCLUSIONS: The prevalence of CDL is high among patients with AC. When a validated model is used, application of cutoffs for ALT, AlkPhos, and CBD diameter can effectively triage patients with low and high likelihood for CDL to surgery or ERCP, respectively.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Chisholm PR, Patel AH, Law RJ, et al. Preoperative predictors of choledocholithiasis in patients presenting with acute calculous cholecystitis. Gastrointest Endosc. 2018. PMID: 30465770. doi:10.1016/j.gie.2018.11.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。